~~<i id='86241BBC26'><strike id='86241BBC26'><tt id='86241BBC26'><pre id='86241BBC26'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：knowledge 2025-09-28 02:27:38 - browse：27

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare Advantage beneficiaries sue Humana over algorithm use

hotspot

focus

explore

leisure time

hotspot

leisure time

9:49AmandaZurawski,whodevelopedsepsisandnearlydiedafterbeingrefusedanabortionwhenherwaterbrokeat18we

WSS

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Violet CEO on training clinicians to promote more inclusive care

SNAP should offer more nutrition education

HCA sued by state AG for quality issues at Mission Health

Keeping primary care docs in field isn't impossible, says AAFP CEO

Flint parents haunted by uncertainty, fears of lead poisoning

leisure time

focus

hotspot

Heart attack and stroke risk calculators need revising

How to keep neuroscience’s past racism from being its future

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Alnylam reports growth in sales of rare disease treatments

Alkermes shareholders re

Late stage cancers on the rise after pandemic delayed screenings

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Heart attack and stroke risk calculators need revising

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

focus

CDC recommends RSV monoclonal antibody for infants

Three trends to watch in biotech in 2024

2 officers injured in shooting in Orlando, police say

HCA sued by state AG for quality issues at Mission Health

A controversial new treatment promises to make little people taller

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

explore

leisure time

hotspot

leisure time